1,2,4,6-Tetra-O-galloyl-β-D-glucose
1,2,4,6-Tetra-O-galloyl-β-D-glucose is an acetylcholinesterase inhibitor with an IC50 of 1.5 μM against human targets. 1,2,4,6-Tetra-O-galloyl-β-D-glucose inhibits the aggregation of amyloid-β. 1,2,4,6-Tetra-O-galloyl-β-D-glucose exhibits anti-herpesvirus activity against both HSV-1 and HSV-2 in vitro. 1,2,4,6-Tetra-O-galloyl-β-D-glucose possesses superoxide dismutase-like antioxidant activity, and also inhibits tyrosinase and hyaluronidase. 1,2,4,6-Tetra-O-galloyl-β-D-glucose can be used in studies related to Alzheimer's disease, herpesvirus infection and antioxidation.
For research use only. We do not sell to patients.
- CAS No.: 84297-49-4
- Formula: C34H28O22
- Molecular Weight:788.57
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
|
HSV-1 |
HSV-2 |
hAChE |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Vero | IC50 |
10.77 μM
|
Inhibition of herpes simplex virus type 1 (HSV-1) multiplication in Vero cells by plaque reduction antiviral assay, incubated for 72 hrs post-infection.
Inhibition of herpes simplex virus type 1 (HSV-1) multiplication in Vero cells by plaque reduction antiviral assay, incubated for 72 hrs post-infection.
|
21213355 |
| Vero | IC50 |
24.73 μM
|
Inhibition of herpes simplex virus type 2 (HSV-2) multiplication in Vero cells by plaque reduction antiviral assay, incubated for 72 hrs post-infection.
Inhibition of herpes simplex virus type 2 (HSV-2) multiplication in Vero cells by plaque reduction antiviral assay, incubated for 72 hrs post-infection.
|
21213355 |
| Vero | IC50 |
11.29 μM
|
Inhibition of herpes simplex virus type 1 (HSV-1) attachment to Vero cells by viral attachment assay, incubated at 4 °C for 80 mins.
Inhibition of herpes simplex virus type 1 (HSV-1) attachment to Vero cells by viral attachment assay, incubated at 4 °C for 80 mins.
|
21213355 |
| Vero | IC50 |
53.13 μM
|
Inhibition of herpes simplex virus type 1 (HSV-1) penetration into Vero cells by viral penetration assay, added post-attachment and incubated at 37 °C for 10 mins.
Inhibition of herpes simplex virus type 1 (HSV-1) penetration into Vero cells by viral penetration assay, added post-attachment and incubated at 37 °C for 10 mins.
|
21213355 |
In Vitro
1,2,4,6-Tetra-O-galloyl-β-D-glucose (compound 10) inhibits the aggregation of human β-amyloid (1-42) peptide with an IC50 of 2.5 μM, and inhibits the activity of recombinant human acetylcholinesterase with an IC50 of 1.5 μM[1].
1,2,4,6-Tetra-O-galloyl-β-D-glucose (1246TGG) shows low cytotoxicity against Vero cells after 72 h, with a CC50 greater than 253.63 μM; it inhibits the proliferation of HSV-1 and HSV-2 in Vero cells, with corresponding IC50 values of 10.77 μM and 24.73 μM, and selectivity indices greater than 23.55 and 10.26, respectively[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose does not induce significant changes in ATP levels in Vero cells at concentrations below 63.41 μM, whereas higher concentrations alter ATP levels[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose potently inhibits the adhesion of HSV-1 to Vero cells, with an IC50 of 11.29 μM; weakly inhibits the invasion of HSV-1 into Vero cells, with an IC50 of 53.13 μM; and directly inactivates cell-free HSV-1 particles, with an IC50 of 9.53 μM[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose (15.85-31.70 μM; added at 0-12 h p.i., harvested at 24 h; 2 h pre-incubation) inhibits the proliferation of HSV-1 in Vero cells; its main antiviral effect occurs within 3 h post-infection, and its mechanism of action is not achieved through interaction with host cells before viral entry into host cells[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose (31.70 μM; added at 2 h p.i., RNA harvested at 3-9 h p.i.) inhibits RNA synthesis of HSV-1 early (UL52) and late (UL27) genes in infected Vero cells[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose (31.70 μM; added at 2 h p.i., DNA harvested at 24 h p.i.) potently inhibits HSV-1 DNA replication in infected Vero cells[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose (31.70 μM; added at 2 h p.i., cells fixed at 9 h, 20 h p.i.) reduces the synthesis of HSV-1 glycoprotein B in infected Vero cells[2].
1,2,4,6-Tetra-O-galloyl-β-D-glucose exhibits significant superoxide dismutase (SOD)-like antioxidant activity (EC50: 1.55 μM); it inhibits tyrosinase (IC50: 0.59 mM) and hyaluronidase (IC50: 0.68 mM)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Vero cells infected with HSV-1
-
Concentration:31.70 μM
-
Incubation Time:Added at 2 h p.i., cells fixed at 9 h, 20 h p.i.
-
Result:Repressed gB synthesis at 9 h p.i. compared to untreated cells.
Resulted in barely detectable fluorescence indicating gB presence at 20 h p.i., while untreated cells showed residual fluorescence from progeny virus release.
Chemical Information
-
CAS No. 84297-49-4
-
Appearance Solid
-
Molecular Weight 788.57
-
Formula C34H28O22
-
Color White to off-white
-
SMILES
O=C(C1=CC(O)=C(C(O)=C1)O)O[C@H]2[C@@H](O[C@@H]([C@H]([C@@H]2O)OC(C3=CC(O)=C(C(O)=C3)O)=O)COC(C4=CC(O)=C(C(O)=C4)O)=O)OC(C5=CC(O)=C(C(O)=C5)O)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Amyloid: Congo Red Amyloid Staining
Congo red amyloid staining is a histochemical method used to detect extracellular amyloid deposits in tissue sections based on the affinity of Congo red dye for β-pleated sheet-rich protein aggregates. When bound to amyloid, Congo red produces characteristic apple-green birefringence under polarized light microscopy, which is widely regarded as a diagnostic feature of amyloid deposition in histopathology. The diagnostic principle relies on the combination of dye binding (congophilia) and optical anisotropy under polarized illumination, which distinguishes amyloid from most non-amyloid eosinophilic extracellular deposits in routine histological evaluation. Amyloid identification by Congo red staining remains a cornerstone in diagnostic pathology despite the availability of adjunct methods such as immunohistochemistry and mass spectrometry, particularly because of its ability to localize deposits directly within tissue architecture. The specificity of Congo red-positive deposits is incre
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
-
Data Sheet (299 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- 1,2,4,6-Tetra-O-galloyl-β-D-glucose
- 84297-49-4
- Amyloid-β
- HSV
- Cholinesterase (ChE)
- Tyrosinase
- HSV-1 early gene RNA synthesis
- amyloid-β aggregation
- acetylcholinesterase
- HSV-1 late gene RNA synthesis
- herpes simplex virus infection
- Alzheimer's disease
- HSV-2
- amyloid-β (1-42) peptide
- Vero cells
- HSV-1
- Inhibitor
- inhibitor
- inhibit